Literature DB >> 9496911

Correlation between reduction of metastasis in the MDA-MB-435 model system and increased expression of the Kai-1 protein.

K K Phillips1, A E White, D J Hicks, D R Welch, J C Barrett, L L Wei, B E Weissman.   

Abstract

Using microcell-mediated transfer of a normal chromosome 11 into the highly metastatic MDA-MB-435 human breast carcinoma cell line, we previously showed that human chromosome 11 contains a metastasis-suppressor gene for breast cancer. A known metastasis-suppressor gene, kai-1, and a related family member, tapa-1, have been mapped to chromosome 11p11.2 and 11p15.5, respectively. To determine if these genes are responsible for the metastasis suppression seen in our microcell hybrids, we examined their expression by western blot analysis. Although tapa-1 expression did not significantly correlate with metastasis suppression, kai-1 production was dramatically increased in the metastasis-suppressed chromosome 11 microcell hybrids and unchanged in the metastatic chromosome 6 controls. Transfection of full-length kai-1 cDNA into MDA-MB-435 cells resulted in clones that did not have a significantly decreased in vivo incidence of lung metastases. However, western blot analysis showed that the primary tumors and the metastatic lesions of the transfectants had decreased levels of kai-1 protein compared with the inoculated cells. Furthermore, several of the transfectant clones expressed heavily modified kai-1 protein compared with that of the microcell hybrids. Our data indicate that protein modification may affect the normal function of kai-1 in vivo and that a threshold level of kai-1 protein expression may be necessary for suppression of the metastatic phenotype.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9496911

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  15 in total

1.  Analysis of mechanisms underlying BRMS1 suppression of metastasis.

Authors:  R S Samant; M J Seraj; M M Saunders; T S Sakamaki; L A Shevde; J F Harms; T O Leonard; S F Goldberg; L Budgeon; W J Meehan; C R Winter; N D Christensen; M F Verderame; H J Donahue; D R Welch
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 2.  Tetraspanins: push and pull in suppressing and promoting metastasis.

Authors:  Margot Zöller
Journal:  Nat Rev Cancer       Date:  2008-12-11       Impact factor: 60.716

3.  Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases.

Authors:  Andreas M Stark; Kerrin Tongers; Nicolai Maass; H Maximilian Mehdorn; Janka Held-Feindt
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-08       Impact factor: 4.553

Review 4.  Metastasis suppressor genes at the interface between the environment and tumor cell growth.

Authors:  Douglas R Hurst; Danny R Welch
Journal:  Int Rev Cell Mol Biol       Date:  2011       Impact factor: 6.813

Review 5.  Pathobiology of brain metastases.

Authors:  N Nathoo; A Chahlavi; G H Barnett; S A Toms
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

Review 6.  Genomics screens for metastasis genes.

Authors:  Jinchun Yan; Qihong Huang
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

7.  Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients.

Authors:  C I Huang; N Kohno; E Ogawa; M Adachi; T Taki; M Miyake
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

Review 8.  Metastasis suppressors and the tumor microenvironment.

Authors:  Leah M Cook; Douglas R Hurst; Danny R Welch
Journal:  Semin Cancer Biol       Date:  2010-12-17       Impact factor: 15.707

Review 9.  Genetic basis of human breast cancer metastasis.

Authors:  M T Debies; D R Welch
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-10       Impact factor: 2.673

10.  Identification and validation of genes with expression patterns inverse to multiple metastasis suppressor genes in breast cancer cell lines.

Authors:  Natascia Marino; Joshua W Collins; Changyu Shen; Natasha J Caplen; Anand S Merchant; Yesim Gökmen-Polar; Chirayu P Goswami; Takashi Hoshino; Yongzhen Qian; George W Sledge; Patricia S Steeg
Journal:  Clin Exp Metastasis       Date:  2014-08-03       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.